Logo image of LNTH

LANTHEUS HOLDINGS INC (LNTH) Stock Fundamental Analysis

NASDAQ:LNTH - Nasdaq - US5165441032 - Common Stock - Currency: USD

78.23  -2.61 (-3.23%)

After market: 80 +1.77 (+2.26%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to LNTH. LNTH was compared to 190 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making LNTH a very profitable company, without any liquidiy or solvency issues. LNTH is growing strongly while it also seems undervalued. This is an interesting combination With these ratings, LNTH could be worth investigating further for value and growth and quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

LNTH had positive earnings in the past year.
In the past year LNTH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LNTH reported negative net income in multiple years.
Each year in the past 5 years LNTH had a positive operating cash flow.
LNTH Yearly Net Income VS EBIT VS OCF VS FCFLNTH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M 500M

1.2 Ratios

LNTH has a Return On Assets of 20.86%. This is amongst the best in the industry. LNTH outperforms 97.87% of its industry peers.
With an excellent Return On Equity value of 36.25%, LNTH belongs to the best of the industry, outperforming 98.40% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 29.79%, LNTH belongs to the top of the industry, outperforming 99.47% of the companies in the same industry.
Industry RankSector Rank
ROA 20.86%
ROE 36.25%
ROIC 29.79%
ROA(3y)4.55%
ROA(5y)3.98%
ROE(3y)10.32%
ROE(5y)11.2%
ROIC(3y)N/A
ROIC(5y)N/A
LNTH Yearly ROA, ROE, ROICLNTH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200 300 400 500

1.3 Margins

LNTH's Profit Margin of 28.57% is amongst the best of the industry. LNTH outperforms 97.34% of its industry peers.
In the last couple of years the Profit Margin of LNTH has grown nicely.
With an excellent Operating Margin value of 31.69%, LNTH belongs to the best of the industry, outperforming 98.94% of the companies in the same industry.
LNTH's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 64.78%, LNTH is in the better half of the industry, outperforming 67.02% of the companies in the same industry.
In the last couple of years the Gross Margin of LNTH has grown nicely.
Industry RankSector Rank
OM 31.69%
PM (TTM) 28.57%
GM 64.78%
OM growth 3Y88.56%
OM growth 5Y16.03%
PM growth 3YN/A
PM growth 5Y16.4%
GM growth 3Y13.64%
GM growth 5Y4.73%
LNTH Yearly Profit, Operating, Gross MarginsLNTH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

8

2. Health

2.1 Basic Checks

LNTH has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
LNTH has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, LNTH has more shares outstanding
The debt/assets ratio for LNTH has been reduced compared to a year ago.
LNTH Yearly Shares OutstandingLNTH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
LNTH Yearly Total Debt VS Total AssetsLNTH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 5.98 indicates that LNTH is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.98, LNTH belongs to the top of the industry, outperforming 82.98% of the companies in the same industry.
The Debt to FCF ratio of LNTH is 1.49, which is an excellent value as it means it would take LNTH, only 1.49 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.49, LNTH belongs to the top of the industry, outperforming 89.36% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that LNTH is not too dependend on debt financing.
LNTH has a Debt to Equity ratio of 0.00. This is in the better half of the industry: LNTH outperforms 68.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.49
Altman-Z 5.98
ROIC/WACC3.48
WACC8.55%
LNTH Yearly LT Debt VS Equity VS FCFLNTH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

LNTH has a Current Ratio of 1.65. This is a normal value and indicates that LNTH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.65, LNTH is doing worse than 72.34% of the companies in the same industry.
LNTH has a Quick Ratio of 1.56. This is a normal value and indicates that LNTH is financially healthy and should not expect problems in meeting its short term obligations.
LNTH has a Quick ratio of 1.56. This is comparable to the rest of the industry: LNTH outperforms 40.96% of its industry peers.
LNTH does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.56
LNTH Yearly Current Assets VS Current LiabilitesLNTH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

LNTH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.63%, which is quite good.
LNTH shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 45.36% yearly.
Looking at the last year, LNTH shows a very strong growth in Revenue. The Revenue has grown by 24.15%.
The Revenue has been growing by 30.43% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)18.63%
EPS 3Y121.92%
EPS 5Y45.36%
EPS Q2Q%15.65%
Revenue 1Y (TTM)24.15%
Revenue growth 3Y56.32%
Revenue growth 5Y30.43%
Sales Q2Q%18.37%

3.2 Future

The Earnings Per Share is expected to grow by 13.05% on average over the next years. This is quite good.
The Revenue is expected to grow by 13.40% on average over the next years. This is quite good.
EPS Next Y10.34%
EPS Next 2Y6.81%
EPS Next 3Y7.37%
EPS Next 5Y13.05%
Revenue Next Year18.4%
Revenue Next 2Y11.58%
Revenue Next 3Y11.6%
Revenue Next 5Y13.4%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LNTH Yearly Revenue VS EstimatesLNTH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
LNTH Yearly EPS VS EstimatesLNTH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.27, the valuation of LNTH can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 95.21% of the companies listed in the same industry.
LNTH's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.63.
With a Price/Forward Earnings ratio of 11.01, the valuation of LNTH can be described as very reasonable.
Based on the Price/Forward Earnings ratio, LNTH is valued cheaper than 96.28% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, LNTH is valued rather cheaply.
Industry RankSector Rank
PE 11.27
Fwd PE 11.01
LNTH Price Earnings VS Forward Price EarningsLNTH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

93.09% of the companies in the same industry are more expensive than LNTH, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LNTH indicates a rather cheap valuation: LNTH is cheaper than 92.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.37
EV/EBITDA 9.91
LNTH Per share dataLNTH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
LNTH has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.09
PEG (5Y)0.25
EPS Next 2Y6.81%
EPS Next 3Y7.37%

0

5. Dividend

5.1 Amount

LNTH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LANTHEUS HOLDINGS INC

NASDAQ:LNTH (2/21/2025, 8:00:00 PM)

After market: 80 +1.77 (+2.26%)

78.23

-2.61 (-3.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)02-26 2025-02-26/bmo
Inst Owners110.89%
Inst Owner Change7.09%
Ins Owners1.47%
Ins Owner Change-0.32%
Market Cap5.44B
Analysts82.11
Price Target136.76 (74.82%)
Short Float %10.55%
Short Ratio8.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.75%
Min EPS beat(2)-3.57%
Max EPS beat(2)7.07%
EPS beat(4)3
Avg EPS beat(4)7.22%
Min EPS beat(4)-3.57%
Max EPS beat(4)18.05%
EPS beat(8)7
Avg EPS beat(8)13.42%
EPS beat(12)11
Avg EPS beat(12)25.14%
EPS beat(16)15
Avg EPS beat(16)92.7%
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-0.1%
Max Revenue beat(2)1.1%
Revenue beat(4)3
Avg Revenue beat(4)1.62%
Min Revenue beat(4)-0.1%
Max Revenue beat(4)4.1%
Revenue beat(8)6
Avg Revenue beat(8)2.5%
Revenue beat(12)10
Avg Revenue beat(12)5.64%
Revenue beat(16)14
Avg Revenue beat(16)4.97%
PT rev (1m)0%
PT rev (3m)-6.82%
EPS NQ rev (1m)1.82%
EPS NQ rev (3m)-2.58%
EPS NY rev (1m)0.3%
EPS NY rev (3m)0.9%
Revenue NQ rev (1m)0.21%
Revenue NQ rev (3m)-1.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE 11.27
Fwd PE 11.01
P/S 3.63
P/FCF 14.37
P/OCF 10.89
P/B 4.61
P/tB 5.76
EV/EBITDA 9.91
EPS(TTM)6.94
EY8.87%
EPS(NY)7.11
Fwd EY9.09%
FCF(TTM)5.45
FCFY6.96%
OCF(TTM)7.18
OCFY9.18%
SpS21.53
BVpS16.97
TBVpS13.59
PEG (NY)1.09
PEG (5Y)0.25
Profitability
Industry RankSector Rank
ROA 20.86%
ROE 36.25%
ROCE 37.48%
ROIC 29.79%
ROICexc 94.46%
ROICexgc 229.39%
OM 31.69%
PM (TTM) 28.57%
GM 64.78%
FCFM 25.3%
ROA(3y)4.55%
ROA(5y)3.98%
ROE(3y)10.32%
ROE(5y)11.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y135.85%
ROICexcg growth 5Y29.76%
ROICexc growth 3Y189.36%
ROICexc growth 5Y23.7%
OM growth 3Y88.56%
OM growth 5Y16.03%
PM growth 3YN/A
PM growth 5Y16.4%
GM growth 3Y13.64%
GM growth 5Y4.73%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.49
Debt/EBITDA 0
Cap/Depr 193.42%
Cap/Sales 8.06%
Interest Coverage 250
Cash Conversion 93.02%
Profit Quality 88.54%
Current Ratio 1.65
Quick Ratio 1.56
Altman-Z 5.98
F-Score6
WACC8.55%
ROIC/WACC3.48
Cap/Depr(3y)73.29%
Cap/Depr(5y)87.08%
Cap/Sales(3y)3.96%
Cap/Sales(5y)4.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.63%
EPS 3Y121.92%
EPS 5Y45.36%
EPS Q2Q%15.65%
EPS Next Y10.34%
EPS Next 2Y6.81%
EPS Next 3Y7.37%
EPS Next 5Y13.05%
Revenue 1Y (TTM)24.15%
Revenue growth 3Y56.32%
Revenue growth 5Y30.43%
Sales Q2Q%18.37%
Revenue Next Year18.4%
Revenue Next 2Y11.58%
Revenue Next 3Y11.6%
Revenue Next 5Y13.4%
EBIT growth 1Y152.98%
EBIT growth 3Y194.75%
EBIT growth 5Y51.34%
EBIT Next Year24.69%
EBIT Next 3Y11.62%
EBIT Next 5Y13.27%
FCF growth 1Y119.88%
FCF growth 3Y279.62%
FCF growth 5Y39.01%
OCF growth 1Y162.37%
OCF growth 3Y165.02%
OCF growth 5Y37.91%